glucose, (beta-d)-isomer has been researched along with Nasopharyngeal Carcinoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Y; Li, Z; Liu, S | 1 |
| Chen, MK; Chen, PJ; Chuang, YC; Ho, HY; Hsieh, MJ; Lin, CC; Lo, YS | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Nasopharyngeal Carcinoma
| Article | Year |
|---|---|
Salidroside suppresses the activation of nasopharyngeal carcinoma cells via targeting miR-4262/GRP78 axis.
Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Proliferation; Endoplasmic Reticulum Chaperone BiP; Gene Expression Regulation, Neoplastic; Glucosides; Humans; Mice; Mice, Nude; MicroRNAs; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phenols | 2022 |
Luteolin-7-O-glucoside inhibits cell proliferation and modulates apoptosis through the AKT signaling pathway in human nasopharyngeal carcinoma.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Flavones; Glucosides; Humans; Nasopharyngeal Carcinoma; Nasopharyngeal Neoplasms; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Signal Transduction | 2021 |